71 results
424B3
CDXC
Chromadex Corp
17 Nov 22
Prospectus supplement
4:03pm
or discounts or concessions allowed to such broker-dealer(s), where applicable, (v) that such broker-dealer(s) did not conduct any investigation to verify
8-K
EX-10.1
cinq6t
11 Oct 22
ChromaDex and Nestlé Health Science Announce New Niagen® Commercial Supply Agreement and $5 Million Investment
4:05pm
8-K
EX-10.2
jq4sb
3 Oct 22
Entry into a Material Definitive Agreement
6:43am
8-K
EX-10.3
6mibigsqzc n7a1x58k
3 Oct 22
Entry into a Material Definitive Agreement
6:43am
8-K
EX-10.1
4j0k3xaw4o
3 Oct 22
Entry into a Material Definitive Agreement
6:43am
8-K
EX-10.1
9464yqyv 2vffcj4
10 Aug 22
ChromaDex Corporation Reports Second Quarter 2022 Financial Results
4:06pm
8-K
EX-99.2
q26 ake4gp2gg67to683
12 May 22
ChromaDex Corporation Reports First Quarter 2022 Financial Results
4:03pm
8-K
EX-99.1
9qiamc
12 May 22
ChromaDex Corporation Reports First Quarter 2022 Financial Results
4:03pm
8-K
EX-99.2
4nj9e7 6usldfryew
9 Mar 22
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2021 Results
4:01pm
424B3
4x9y b7dvrao
22 Apr 21
Prospectus supplement
4:31pm